Peptris

Peptris is an AI-driven drug discovery startup that develops a computational platform to accelerate preclinical molecule design and selection. The company combines unsupervised learning, generative AI and bespoke ML pipelines to design novel chemical entities (NCEs), repurpose approved drugs and rescue shelved molecules. It operates a virtual R&D model that leverages external CROs and biotech partners for wet-lab validation, and monetizes via licensing, milestone payments and royalties while partnering with academia and pharma.